Insider Transactions
Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Jun 09, 2021 |
Trans History: 31
|
Chief Financial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,782 | -- | 36,696 |
Jun 09, 2021 |
Trans History: 92
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,783 | -- | 39,958 |
Jun 09, 2021 |
Trans History: 99
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,783 | -- | 21,646 |
Jun 09, 2021 |
Trans History: 9
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,783 | -- | 11,425 |
Jun 09, 2021 |
Trans History: 18
|
Chief Strategy Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,891 | -- | 21,893 |
Jun 09, 2021 |
Trans History: 119
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,783 | -- | 55,146 |
Jun 09, 2021 |
Trans History: 12
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,783 | -- | 12,036 |
Jun 09, 2021 |
Trans History: 64
|
SVP, Business Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 6,744 | -- | 23,377 |
May 26, 2021 |
Trans History: 110
|
Director, Chairman of the Board | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 2,049 | -- | -- |
May 25, 2021 |
Trans History: 110
|
Director, Chairman of the Board | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 22,249 | -- | 2,049 |
May 21, 2021 |
Trans History: 110
|
Director, Chairman of the Board | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 702 | -- | 24,298 |
May 04, 2021 |
Trans History: 54
|
General Counsel | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,000 | -- | 18,971 |
Apr 19, 2021 |
Trans History: 31
|
Vice President and CFO | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | 30,914 |
Apr 19, 2021 |
Trans History: 31
|
Vice President and CFO | Form 3 | Initial Statement of Beneficial Ownership of Securities | 27,347 | -- | -- |
Apr 19, 2021 |
Trans History: 31
|
Vice President and CFO | Form 3 | Initial Statement of Beneficial Ownership of Securities | 13,333 | -- | -- |
Mar 19, 2021 |
Trans History: 78
|
President | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 22,878 | -- | 84,999 |
Mar 19, 2021 |
Trans History: 110
|
Director, Chairman of the Board | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 33,716 | -- | 347,149 |
Mar 19, 2021 |
Trans History: 54
|
General Counsel | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,816 | -- | 15,809 |
Mar 19, 2021 |
Trans History: 54
|
Chief Operating Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 6,023 | -- | 57,530 |
Mar 19, 2021 |
Trans History: 47
|
Chief Financial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,816 | -- | 22,469 |
Mar 19, 2021 |
Trans History: 64
|
SVP, Business Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,816 | -- | 23,916 |
Mar 19, 2021 |
Trans History: 64
|
SVP, Business Development | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 5,000 | -- | -- |
Mar 10, 2021 |
Trans History: 78
|
President | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 24,905 | -- | 75,469 |
Mar 10, 2021 |
Trans History: 110
|
Director, Chairman of the Board | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 32,771 | -- | 330,326 |
Mar 10, 2021 |
Trans History: 54
|
General Counsel | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,588 | -- | 12,749 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.